Incidence and mortality trends for biliary tract cancers in Austria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and mortality trends for biliary tract cancers in Austria

Published:2013-10-02 Issue:7 Volume:34 Page:1102-1108
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Pinter Matthias¹,Hucke Florian¹,Zielonke Nadine²,Waldhör Thomas³,Trauner Michael¹,Peck-Radosavljevic Markus¹,Sieghart Wolfgang¹

Affiliation:

1. Division of Gastroenterology & Hepatology and Comprehensive Cancer Center; AKH & Medical University of Vienna; Vienna Austria

2. Austrian National Cancer Registry; Statistics Austria; Vienna Austria

3. Department of Epidemiology; Medical University of Vienna; Vienna Austria

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12325/fullpdf

Reference42 articles.

1. Biliary tract cancers;Groen;N Engl J Med,1999

2. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification;Ishiguro;Cancer Causes Control,2008

3. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma;Palmer;J Hepatol,2012

4. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer;Skipworth;Aliment Pharmacol Ther,2011

5. Risk factors for cholangiocarcinoma;Tyson;Hepatology,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer;JHEP Reports;2023-03

2. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer;Cancers;2023-02-07

3. Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer;International Journal of Cancer;2022-12

4. Adjuvant treatment for the elderly patient with resected gallbladder cancer: a SEER-Medicare analysis;Journal of Gastrointestinal Oncology;2022-12

5. Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27;Cancers;2022-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3